These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38315668)

  • 1. Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries.
    Ajulo S; Awosile B
    PLoS One; 2024; 19(2):e0297921. PubMed ID: 38315668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between antimicrobial consumption and resistance rate of Escherichia coli in hospital settings.
    Abdullah S; Rahman SU; Muhammad F; Mohsin M
    J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antimicrobial consumption on Escherichia coli resistance: assessment and forecasting using Dynamic Regression models in a French university hospital (2014-2019).
    Laffont-Lozes P; Salipante F; Leguelinel-Blache G; Dunyach-Remy C; Lavigne JP; Sotto A; Larcher R
    Int J Antimicrob Agents; 2023 May; 61(5):106768. PubMed ID: 36878409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals: Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA) Report.
    ; ;
    EFSA J; 2017 Jul; 15(7):e04872. PubMed ID: 32625542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.
    Laffont-Lozes P; Larcher R; Salipante F; Leguelinel-Blache G; Dunyach-Remy C; Lavigne JP; Sotto A; Loubet P
    Antimicrob Resist Infect Control; 2023 Sep; 12(1):100. PubMed ID: 37697357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012-2013.
    Vu TVD; Do TTN; Rydell U; Nilsson LE; Olson L; Larsson M; Hanberger H; Choisy M; Dao TT; van Doorn HR; Nguyen VK; Nguyen VT; Wertheim HFL;
    J Glob Antimicrob Resist; 2019 Sep; 18():269-278. PubMed ID: 31201995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
    J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic consumption and its influence on the resistance in Enterobacteriaceae.
    Sedláková MH; Urbánek K; Vojtová V; Suchánková H; Imwensi P; Kolář M
    BMC Res Notes; 2014 Jul; 7():454. PubMed ID: 25027417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018-2021.
    Murungi M; Ndagije HB; Kiggundu R; Kesi DN; Waswa JP; Rajab K; Barigye M; Serwanga A; Manirakiza L; Kasujja H; Kaweesi D; Joshi MP; Namugambe J; Konduri N
    J Infect Public Health; 2023 Dec; 16 Suppl 1():45-51. PubMed ID: 37926595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014-2016.
    Wushouer H; Zhang ZX; Wang JH; Ji P; Zhu QF; Aishan R; Shi LW
    J Infect Public Health; 2018; 11(3):339-346. PubMed ID: 29017750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.
    Allel K; Day L; Hamilton A; Lin L; Furuya-Kanamori L; Moore CE; Van Boeckel T; Laxminarayan R; Yakob L
    Lancet Planet Health; 2023 Apr; 7(4):e291-e303. PubMed ID: 37019570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.
    Saeed DK; Farooqi J; Shakoor S; Hasan R
    BMC Infect Dis; 2021 Dec; 21(1):1231. PubMed ID: 34876041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae.
    Alvarez-Uria G; Gandra S; Mandal S; Laxminarayan R
    Int J Infect Dis; 2018 Mar; 68():50-53. PubMed ID: 29410253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe.
    Robertson J; Vlahović-Palčevski V; Iwamoto K; Högberg LD; Godman B; Monnet DL; Garner S; Weist K; ;
    Front Pharmacol; 2021; 12():639207. PubMed ID: 34220495
    [No Abstract]   [Full Text] [Related]  

  • 18. Does Fluoroquinolones and Third-Generation Cephalosporins Restriction Reverse Extended-Spectrum β-Lactamases
    Stanić Benić M; Palčevski D; Milanič R; Skočibušić N; Abram M; Vlahović-Palčevski V
    Microb Drug Resist; 2021 Sep; 27(9):1159-1166. PubMed ID: 33739871
    [No Abstract]   [Full Text] [Related]  

  • 19. Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health Index.
    Zhou N; Cheng Z; Zhang X; Lv C; Guo C; Liu H; Dong K; Zhang Y; Liu C; Chang YF; Chen S; Guo X; Zhou XN; Li M; Zhu Y
    Infect Dis Poverty; 2022 Aug; 11(1):92. PubMed ID: 35996187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramammary and systemic use of antimicrobials and their association with resistance in generic Escherichia coli recovered from fecal samples from Canadian dairy herds: A cross-sectional study.
    Fonseca M; Heider LC; Stryhn H; McClure JT; Léger D; Rizzo D; Warder L; Dufour S; Roy JP; Kelton DF; Renaud D; Barkema HW; Sanchez J
    Prev Vet Med; 2023 Jul; 216():105948. PubMed ID: 37263090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.